FMR1 and fragile X syndrome: This suggests that the downstream molecular consequences of the absence of FMRP in neurons are well conserved in mammals and that the wealth of altered pathways we observed in the Fmr1-KO mouse model can provide a valuable resource for future studies in FXS patients and the design of therapeutic approaches.